Two non-canonical receptor tyrosine kinases (RTKs), Anaplastic lymphoma kinase (ALK) and Receptor Like Tyrosine Kinase (RYK), were reported to target miR-1271 in analysis of post-mortem AD and T2D tissues. This evidence concerns the gene ALK and type 2 diabetes mellitus.